The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy

Tian Wang,1,* Feng Lin,2,* Yujing Huang,2 Guowei Qian,2 Wenxi Yu,2 Haiyan Hu,2 Tong Ji,3 Lina Tang,2 Yang Yao2 1The Eighth People’s Hospital of Shanghai, Shanghai, People’s Republic of China; 2Shanghai Sixth People’s Hospital, Shanghai Jiaotong University, Shanghai, People’s Republic...

Full description

Bibliographic Details
Main Authors: Wang T, Lin F, Huang Y, Qian G, Yu W, Hu H, Ji T, Tang L, Yao Y
Format: Article
Language:English
Published: Dove Medical Press 2022-10-01
Series:Cancer Management and Research
Subjects:
anlotinib
refractory metastatic osteosarcoma
combination therapy
Online Access:https://www.dovepress.com/the-combination-of-anlotinib-and-gemcitabinedocetaxel-in-patients-with-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/the-combination-of-anlotinib-and-gemcitabinedocetaxel-in-patients-with-peer-reviewed-fulltext-article-CMAR

Similar Items